U.S. Pharmacogenomics Markets Key Alliances and Pro-Active Networking Efforts Essential for Success

1
U.S. Pharmacogenomics MarketsKey Alliances
and Pro-Active Networking Efforts Essential for
Success

• "Investors and established companies should begin
  scouting start-up companies and academic
  laboratories for innovative technologies."

Drug Discovery and Biotechnology Analyst
Team Frost Sullivan
2
Key Features

• Detailed insights into recent developments and
  trends
• Drivers, restraints, challenges, and strategic
  recommendations
• Analytical insights into current topics and
  emerging
• applications in the pharmacogenomics market
• Market-sizing and competitive analysis
• Market forecasts and opportunity analyses
• Quarterly assessments
• End-user analysis

3
What We Offer

• Coverage The United States
• Proven methodology using extensive primary and
  secondary data as well as research
• Focused information and strategies that cover
  business and technology issues
• Credible data and analyses that highlight
  industry dynamics
• Precise strategies to help you create winning
  business plans

4
Benefits

• Current Market Participants
• Find out where you stand in comparison with the
  competitors
• Assess current and future drivers as well as
  restraints
• Determine and exploit new market share
  opportunities
• New Entrants
• Analyze the associated challenges
• Calculate timescales for strategy implementation
• Position yourself to capitalize on the unmet
  needs of the market
• Investment Community
• Analyze long-term strategies of companies
• Determine which participants will outperform the
  competition
• Assess the attractiveness of investing in the
  market

5
Key Market Participants
Acadia Pharmaceuticals Affymetrix, Inc. Amgen AP
Biotech Applera Corp. Arius Research ArQule AstraZ
eneca Aventis (USA) Base4, Inc. Bayer
(USA) BioMérieux BioTechnology General
Corp. Boehringer Ingelheim (USA) Bristol-Myers
Squibb Co. Clontech Laboratories, Inc. CuraGen
Corp.
Élan (USA) Eli Lilly and Co. EM Industries
(USA) ExonHit Therapeutics Ferring
Pharmaceuticals, Inc. (USA) Genaissance
Pharmaceuticals, Inc. Genentech,
Inc. Genta GlaxoSmithKline Hoffmann-La
Roche Hybrigenics Incyte Pharmaceuticals InterMune
Pharmaceuticals Invitrogen Corp. Lorus
Therapeutics, Inc. Matrix Pharmaceuticals,
Inc. MDS Ocata, Inc.
6
Key Market Participants (contd)
Medicis Merck Microarray Centre Molecular
Templates Nabi Nova Biomedical Novartis
(USA) OmniViz, Inc. Ontario Cancer
Institute Orchid BioSciences, Inc. Orphan
Australia Pty Ltd. Orphan Europe SARL Orphan
Medical, Inc. Orphan Pharmaceuticals Orphan
Pharma International Packard Instrument Co.
Pierre Fabre SA Pfizer Pharmaceuticals
Group PPGx, Inc. Qiagen Genomics Sanofi-Syntélabo
(USA) Sequenom, Inc. Shire Pharmaceuticals Group
(USA) Sigma-Tau Pharmaceuticals, Inc.
(USA) SignalGene, Inc. Swedish Orphan Teva
Pharmaceuticals (USA) Therapeutic Goods
Administration Third Wave Technologies TM
BioScience Corp. Visible Genetics, Inc. YM
Biosciences, Inc.
7
For More Information

• Call toll free 877 GO FROST
• (877.463.7876)
• Fax toll free 888.690.3329
• E-mail myfrost_at_frost.com
• Visit www.frost.com